Get started Log in

HYFT — Mindwalk Holdings Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Market Cap
$54.51m
Enterprise Value
$51.55m
Revenue
CA$15.56m

Brief: ImmunoPrecise Antibodies posts Q1 revenue CAD 5.7 million
14/09/2023 13:57
Immunoprecise Antibodies Ltd expected to post a loss of 20 cents a share - Earnings Preview
08/09/2023 13:38
Brief: Immunoprecise Antibodies Ltd Files For Offering Of Up To $60 Million Of Common Shares - SEC Filing
16/08/2023 11:19
Brief: Immunoprecise Antibodies Ltd Have Opened Dialogue With Ingalls & Snyder And Will Continue To Engage In Discussions With Them
09/08/2023 14:26
Brief: ImmunoPrecise Antibodies Files For Mixed Shelf Of Up To $300 Million
11/07/2023 11:07
Brief: Immunoprecise Reports Financial Results And Recent Business Highlights For Full Fiscal Year 2023
07/07/2023 13:12
Immunoprecise Antibodies Ltd expected to post a loss of 17 cents a share - Earnings Preview
05/07/2023 13:35
Brief: ImmunoPrecise's Subsidiary Talem In Research Collaboration With Astellas
30/03/2023 14:56
Brief: Immunoprecise Antibodies Receives Notice From European Patent Office
27/03/2023 14:04
Brief: Immunoprecise Presents Novel T-Cell Engaging Bispecific Antibodies Addressing A Unique Oncological Target, Tropomyosin Receptor Kinase B, Associated With Poor Prognosis And Survival Rates
23/03/2023 12:23
Immunoprecise Antibodies Ltd reports results for the quarter ended in January - Earnings Summary
16/03/2023 13:32
Brief: IPA Reports Q3 Financial Results
16/03/2023 12:38
Immunoprecise Antibodies Ltd expected to post a loss of 23 cents a share - Earnings Preview
14/03/2023 14:11
Brief: Ipa’S Subsidiary Biostrand And Briacell Announce Artificial Intelligence Collaboration And License Agreement To Discover And Develop Anti-Cancer Antibodies
30/11/2022 13:09
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:17 AM
22/07/2021 16:17